- Home
- TNGX vs NGS Comparison
TNGX vs NGS Comparison
Compare TNGX & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- NGS
- Stock Information
- Founded
- TNGX 2014
- NGS 1998
- Country
- TNGX United States
- NGS United States
- Employees
- TNGX N/A
- NGS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- NGS Oilfield Services/Equipment
- Sector
- TNGX Health Care
- NGS Energy
- Exchange
- TNGX Nasdaq
- NGS Nasdaq
- Market Cap
- TNGX 351.2M
- NGS 312.1M
- IPO Year
- TNGX N/A
- NGS 2002
- Fundamental
- Price
- TNGX $6.01
- NGS $24.48
- Analyst Decision
- TNGX Strong Buy
- NGS Strong Buy
- Analyst Count
- TNGX 6
- NGS 2
- Target Price
- TNGX $12.20
- NGS $32.50
- AVG Volume (30 Days)
- TNGX 2.7M
- NGS 75.2K
- Earning Date
- TNGX 08-06-2025
- NGS 08-13-2025
- Dividend Yield
- TNGX N/A
- NGS N/A
- EPS Growth
- TNGX N/A
- NGS 76.16
- EPS
- TNGX N/A
- NGS 1.34
- Revenue
- TNGX $40,990,000.00
- NGS $161,218,000.00
- Revenue This Year
- TNGX N/A
- NGS $13.56
- Revenue Next Year
- TNGX N/A
- NGS $15.42
- P/E Ratio
- TNGX N/A
- NGS $18.12
- Revenue Growth
- TNGX 10.09
- NGS 22.64
- 52 Week Low
- TNGX $1.03
- NGS $16.70
- 52 Week High
- TNGX $12.02
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- NGS 44.42
- Support Level
- TNGX $5.34
- NGS $24.41
- Resistance Level
- TNGX $6.40
- NGS $25.46
- Average True Range (ATR)
- TNGX 0.50
- NGS 1.02
- MACD
- TNGX -0.02
- NGS -0.32
- Stochastic Oscillator
- TNGX 84.08
- NGS 8.09
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.